AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMUX
  4. [Form 4] Immunic, Inc. Insider Trading Activity

[Form 4] Immunic, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source:

Stock IMUX logo
Immunic Inc

NASDAQ:IMUX

IMUX Rankings

#4847 Ranked by Market Cap
N/A Ranked by Dividends

IMUX Latest News

Aug 7, 2025
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jun 24, 2025
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
Jun 5, 2025
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS
Jun 3, 2025
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering
Jun 2, 2025
Immunic to Participate in Investor, Scientific and Industry Conferences in June

IMUX Latest SEC Filings

Aug 12, 2025
[SCHEDULE 13G/A] Immunic, Inc. SEC Filing
Aug 8, 2025
[SCHEDULE 13G] Immunic, Inc. SEC Filing
Aug 7, 2025
[10-Q] Immunic, Inc. Quarterly Earnings Report
Aug 7, 2025
[8-K] Immunic, Inc. Reports Material Event
Jul 31, 2025
[SCHEDULE 13G] Immunic, Inc. SEC Filing

IMUX Stock Data

83.56M
97.35M
1.35%
51.83%
8.94%
Biotechnology
Pharmaceutical Preparations
United States
NEW YORK